NEWS

News
PHASE ONE Announces New Board Chair: Marc Lebowitz
PHASE ONE Announces New Board Chair: Marc Lebowitz
Read More →
Standing With Our Community: PHASE ONE Supports Firefighters, Shifts Gala to Fall
Standing With Our Community: PHASE ONE Supports Firefighters, Shifts Gala to Fall
Read More →
Breakthrough Kidney Cancer Research Aims to Transform Diagnosis & Treatment
Breakthrough Kidney Cancer Research Aims to Transform Diagnosis & Treatment
Read More →
New Hope for Hereditary Kidney Cancer: PHASE ONE Funds Pioneering Study for HLRCC
New Hope for Hereditary Kidney Cancer: PHASE ONE Funds Pioneering Study for HLRCC
Read More →
Revolutionizing Treatment for Rare Head and Neck Cancer: PHASE ONE Funds Breakthrough Study for NOTCH-Activated Adenoid Cystic Carcinoma
Revolutionizing Treatment for Rare Head and Neck Cancer: PHASE ONE Funds Breakthrough Study for NOTCH-Activated Adenoid Cystic Carcinoma
Read More →
PHASE ONE's Largest FACT Pickleball Social To Date Raises Over $275K for Clinical Cancer Research
PHASE ONE's Largest FACT Pickleball Social To Date Raises Over $275K for Clinical Cancer Research
Read More →
PHASE ONE Community Grants Boost Walk With Sally and LAUSD’s Cancer Support & Education Programs
PHASE ONE Community Grants Boost Walk With Sally and LAUSD’s Cancer Support & Education Programs
Read More →
Breakthrough Turmeric Clinical Trial: PHASE ONE Grant Fuels Hope for Less Toxic Oral Cancer Treatment
Breakthrough Turmeric Clinical Trial: PHASE ONE Grant Fuels Hope for Less Toxic Oral Cancer Treatment
Read More →
Breaking Barriers: PHASE ONE Funds Promising Immunotherapy Research for Metastatic Pancreatic Cancer
Breaking Barriers: PHASE ONE Funds Promising Immunotherapy Research for Metastatic Pancreatic Cancer
Read More →
PHASE ONE’s 25th Anniversary Gala Breaks Records– Raising Over $1.2M for Clinical Cancer Research
PHASE ONE’s 25th Anniversary Gala Breaks Records– Raising Over $1.2M for Clinical Cancer Research
Read More →
Promising New Combination Therapy May Pave the Way for Targeted Treatment in Non-Hodgkin Lymphoma
Promising New Combination Therapy May Pave the Way for Targeted Treatment in Non-Hodgkin Lymphoma
Read More →
PHASE ONE Funds FORCE’s Clinical Research Search & Enroll Program
PHASE ONE Funds FORCE’s Clinical Research Search & Enroll Program
Read More →
Revolutionizing T-cell Acute Lymphoblastic Leukemia (T-ALL) Treatment: A Novel Combination Therapy Offers New Hope
Revolutionizing T-cell Acute Lymphoblastic Leukemia (T-ALL) Treatment: A Novel Combination Therapy Offers New Hope
Read More →
PHASE ONE Foundation Welcomes Three New Board Members: Rebecca Cocco, Paula Selesnick, and Cindy Ruby
PHASE ONE Foundation Welcomes Three New Board Members: Rebecca Cocco, Paula Selesnick, and Cindy Ruby
Read More →
Unlocking New Hope: PHASE ONE Funds Phase I/II Trial Investigating a Novel Approach to Pediatric Cancer Treatment for Solid Tumors
Unlocking New Hope: PHASE ONE Funds Phase I/II Trial Investigating a Novel Approach to Pediatric Cancer Treatment for Solid Tumors
Read More →
PHASE ONE Funds Phase II Trial Using Biomarkers to Match Metastatic ER+ Breast Cancer Patients with Effective Treatments
PHASE ONE Funds Phase II Trial Using Biomarkers to Match Metastatic ER+ Breast Cancer Patients with Effective Treatments
Read More →
PHASE ONE’s 2023 Annual Gala Raises Over $1M for Clinical Cancer Research
PHASE ONE’s 2023 Annual Gala Raises Over $1M for Clinical Cancer Research
Read More →
PHASE ONE Funds Imerman Angels’ Clinical Trial Matching Program
PHASE ONE Funds Imerman Angels’ Clinical Trial Matching Program
Read More →
Grant Announcement for Phase II Study in Multiple Myeloma at USC
Grant Announcement for Phase II Study in Multiple Myeloma at USC
Read More →
Grant Announcement for Study Using NK Cells to Treat Ovarian Cancer at Dana-Farber Cancer Institute
Grant Announcement for Study Using NK Cells to Treat Ovarian Cancer at Dana-Farber Cancer Institute
Read More →
PHASE ONE Funds Children’s Hospital Los Angeles Study of Novel Treatment for Osteosarcoma
PHASE ONE Funds Children’s Hospital Los Angeles Study of Novel Treatment for Osteosarcoma
Read More →
Updates on Dr. Jason Sicklick's Study on Gastrointestinal Stromal Tumors (GISTs)
Updates on Dr. Jason Sicklick's Study on Gastrointestinal Stromal Tumors (GISTs)
Read More →
Recap on The Simms/Mann-UCLA Center for Integrative Oncology's COVID-19 Response
Recap on The Simms/Mann-UCLA Center for Integrative Oncology's COVID-19 Response
Read More →
The SIMMS/MANN-UCLA Center for Integrative Oncology Receives Grant to Support Psychosocial Care For Cancer Patients, Families and Healthcare Workers Amid COVID-19 Pandemic
The SIMMS/MANN-UCLA Center for Integrative Oncology Receives Grant to Support Psychosocial Care For Cancer Patients, Families and Healthcare Workers Amid COVID-19 Pandemic
Read More →
2020 PHASE ONE Annual Gala Update
2020 PHASE ONE Annual Gala Update
Read More →
Clinical Trial Update In Light Of COVID-19
Clinical Trial Update In Light Of COVID-19
Read More →
PHASE ONE Grants Dr. Jason Sicklick $500,000 to Study Gastrointestinal Stromal Tumors (GIST)
PHASE ONE Grants Dr. Jason Sicklick $500,000 to Study Gastrointestinal Stromal Tumors (GIST)
Read More →
Cancer Researchers Receive Grant to Develop Immune-based Therapies for Deadly Brain Tumors
Cancer Researchers Receive Grant to Develop Immune-based Therapies for Deadly Brain Tumors
Read More →